To further investigate the relationship between PPARγ activation and KC polarization as well as IR liver lesions, PPARγ agonists and antagonists were administered to a nonlethal segmental (70%) hepatic warm ischemia mouse model. The gene discussed is PPARG; the disease is Hepatitis.